SynergiaConsulting

Providing clients in the #pharmaceutical, #medicaldevice, #laboratory, and #biotech fields with personalized #consulting services

[SynergiaConsulting @SynergiaLLC]

Fixing just one thing, our latest #blog article, discusses the interconnected nature of organizations, considers a #clinicallaboratory #casestudy. Check it out at: https://t.co/YaeGojTwrH

[CredibleMeds @CredibleMeds]

According to @ASCPharm, Americans 65+ take an average of 5 #prescriptiondrugs each day, not including over-the-counter drugs which can make some of these #Rx drugs deadly due to #ddi. @RayWoosley unpacks this epidemic on @buckmastershow. Listen: https://t.co/sMVS2lr05C

[AbeonaBio @AbeonaBio]

We are at the @ASGCTherapy annual meeting this week presenting preclinical data related to our cystic fibrosis program. See our press release for details: https://t.co/OgL84wDu0G #ASGCT19

[EU Medicines Agency @EMA_News]

EMA and the @EU_Commission have published the #biosimilar guide for #HealthcareProfessionals in eight EU languages. Find them here: https://t.co/nxOQZYHxpX

[U.S. FDA @US_FDA]

If we want to maintain a robust pipeline for antibiotics, it is necessary to change the perception that the costs and risks of antibiotic innovation are too high relative to their expected gains—without weakening antibiotic stewardship.

[CredibleMeds @CredibleMeds]

Tune in to Dr. @RayWoosley at 12:30 PT on @1030_kvoi w/ legendary broadcaster @buckmastershow for their monthly "To Your Health" segment. He will offer tips to work with your pharmacist to ensure you have the right medicine at each visit. Listen live here https://t.co/luhdiC9sDG

[Eric Topol @EricTopol]

Lab test futility :-)
@speedbumpcomic

[SynergiaConsulting @SynergiaLLC]

Congratulations on the feature in @Huffpostparents of @GretaGraceGarb : For people with disabilities, many brands and fashion runways don't reflect their needs or lives. These people are working to change that. https://t.co/Gk9UEK5pBo via @HuffPostParents

[EU Medicines Agency @EMA_News]

Children and babies react differently to #medicines. See how EMA supports the development of medicines tailored for children’s specific therapeutic needs: https://t.co/q4pMU4RXKM

[Eric Topol @EricTopol]

How manipulating the genome offers some hope in rare diseases:
—#HuntingtonDisease https://t.co/bIUDtjH3D7
by @meredithwadman antisense @ionispharma @HDAwareness—#MuscularDystrophy https://t.co/PvUGHgf38P #CRISPR by @antonioregalado @ExonicsTx

[FDA Oncology @FDAOncology]

New #FDAOncology draft guidance provides recommendations to industry on use of #placebos and blinding in randomized controlled trials in development programs for drugs or biological products for hematologic malignancies & oncologic diseases https://t.co/LDhxqHKkB7

[Eric Topol @EricTopol]

1st time I've been able to get my medical data from 1985 -> present
4 health systems @ScrippsHealth @UCSDHealth @ClevelandClinic @umichmedicine + @23andMe + @fitbit +@MyFitnessPal with labs from diff't systems all connected @seqster (trying it <24 hrs)
step in the right direction

[FDA Drug Information @FDA_Drug_Info]

#FDA updates the prescribing information for Keytruda (pembrolizumab) and Tecentriq (atezolizumab) to require the use of an FDA-approved companion diagnostic test: https://t.co/LG18vlljGE.

[Media Affairs @FDAMedia]

FDA approves first generic version of EpiPen https://t.co/UUp1QeC6mI

[Media Affairs @FDAMedia]

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease https://t.co/y1UI4Mq3pc

[Greta Grace Garb 4 Special Kids @GretaGraceGarb]

Check out all the new additions!!!!! Excited to share the latest addition to my #etsy shop: 6-9 Month Squirrel G Tube Bodysuit https://t.co/MRkGO3I0Sr #clothing #children #bodysuit #6-9months #nicu #gtube #gtubeonesie #gtubeclothing #adaptiveclothing #cerebralpalsy

[SynergiaConsulting @SynergiaLLC]

#BAN2401 encouraging results to date https://t.co/eJ6kelWH07

[FDA Drug Information @FDA_Drug_Info]

#FDA is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products: https://t.co/9C7HjbwoCZ.

[AZBio @AZBio]

Thank you @RepDavid for co-sponsoring H.R. 184, the Protect Medical Innovation Act of 2017 and supporting the medtech innovators who are helping to bend the heallthcare cost curve. #RepealDeviceTax

[FDA Drug Information @FDA_Drug_Info]

FDA releases the Biosimilars Action Plan (BAP) to provide information about the key actions the agency is taking to encourage innovation and competition among biologics and the development of biosimilars: https://t.co/OUUBG8M7bH.

[Eric Topol @EricTopol]

The combo of #EHR deep phenotyping and exome sequencing to make the diagnosis https://t.co/EkBRiPfB9T @AJHGNews @GeneticsSociety @CellPressNews @Columbia @ColumbiaScience @ChildrensPhila